Marketscreener, stock market website
072b75d09a7ea6ed0517d3f5887e.-9YzHO4bWBz7Nsfz5qh1XjvYb3ec1-JwQ3LlJ3SFVeY.q69ccIxDDk3KG66qtcMAO1ayNw3L5o0iKTSTQA3NDaO4jmF5o3YbcJhD8w
Logo MarketScreener
Back
Logo MarketScreener

Enter your password

Forgot your password ?
Subscribe
  • Markets
    Stocks
    Top Capitalization
    Hong Kong
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company Calendar
    Equity Analysis
    Most popular
    PRUDENTIAL FINANCIAL, INC.
    RENAULT
    CAPITAL ONE FINANCIAL CORPORATION
    NISSAN MOTOR CO., LTD.
    JPMORGAN CHASE & CO.
    BANK OF NEW YORK MELLON CORPORATION (THE)
    THE GOLDMAN SACHS GROUP, INC.
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indices News
    HANG SENG
    SHANGHAI COMPOSITE
    TOPIX
    SYDNEY ASX
    FTSE 100
    EURO STOXX 50
    S&P 500
    NASDAQ 100
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    HKD / USD
    HKD / EUR
    HKD / CNY
    HKD / JPY
    HKD / GBP
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Funds
    Economy
    Sectors
    Most Read News
    Hot News
    Business Insiders
  • Analysis
    All Articles
    Must Read
    Equity Analysis
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
  • Calendar
    Economic Calendar
    Company Calendar
    Dividend calendar
  • Stock Picks
    All our investments
    Asia, Pacific
    Europe
    United States
  • Portfolios
    Asian Portfolio
    European Portfolio
    USA Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Monthly dividends
    Low volatility
    Dividend Kings
    ESG stocks
    Quality stocks at a reasonable price
    Multibaggers
    Investment Themes
    Homepage
    Blockchain
    Ageing Population
    Bionic engineering
    Private Equity
    Gold and Silver
    Wind energy
  • Trading
    Market Timing
    Hot News
    Pre/Post-market Movers
    Europe
    North America
    Technical Alerts
  • Screeners
    Stocks
    ETF
    Insider transactions
  • Tools
    Dynamic Chart
    Currency Converter
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Pre/Post-market Movers
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Market Cap
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
Hong Kong Edition
Subscribe
  • Homepage
  • Markets
    • Stocks
      • Top Capitalization
      • Hong Kong
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company Calendar
      • Equity Analysis
      • Most popular
      • PRUDENTIAL FINANCIAL, INC.
      • RENAULT
      • CAPITAL ONE FINANCIAL CORPORATION
      • NISSAN MOTOR CO., LTD.
      • JPMORGAN CHASE & CO.
      • BANK OF NEW YORK MELLON CORPORATION (THE)
      • THE GOLDMAN SACHS GROUP, INC.
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indices News
      • HANG SENG
      • SHANGHAI COMPOSITE
      • TOPIX
      • SYDNEY ASX
      • FTSE 100
      • EURO STOXX 50
      • S&P 500
      • NASDAQ 100
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • HKD / USD
      • HKD / EUR
      • HKD / CNY
      • HKD / JPY
      • HKD / GBP
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Funds
    • Economy
    • Sectors
    • Most Read News
    • Hot News
    • Business Insiders
  • Analysis
    • All Articles
    • Must Read
    • Equity Analysis
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
  • Calendar
    • Economic Calendar
    • Company Calendar
    • Dividend calendar
  • Stock Picks
    • All our investments
    • Asia, Pacific
    • Europe
    • United States
  • Portfolios
    • Asian Portfolio
    • European Portfolio
    • USA Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Monthly dividends
      • Low volatility
      • Dividend Kings
      • ESG stocks
      • Quality stocks at a reasonable price
      • Multibaggers
    • Investment Themes
      • Homepage
      • Blockchain
      • Ageing Population
      • Bionic engineering
      • Private Equity
      • Gold and Silver
      • Wind energy
  • Trading
    • Market Timing
    • Hot News
    • Pre/Post-market Movers
      • Europe
      • North America
    • Technical Alerts
  • Screeners
    • Stocks
    • ETF
    • Insider transactions
  • Tools
    • Dynamic Chart
    • Currency Converter
    • Rankings
      • Top Movers
        • Short-Term Gainers & Losers
        • Long-term Gainers & Losers
        • Unusual volumes
        • New Historical Highs
        • New Historical Lows
      • Pre/Post-market Movers
      • Top Fundamentals
        • Fundamental Composite
        • Sales growth
        • Earnings Growth
        • Profitability
        • Finances
      • Rankings Valuation
        • Valuation Composite
        • Market Cap
        • P/E ratio
        • Enterprise value
        • Yield
        • Price to Book (PBR)
        • Free Cash Flow (FCF)
      • Top Consensus
        • Consensus composite
        • Analyst Opinion
        • Target price
        • Opinion Divergences
        • Estimates Revisions
        • Analyst coverage
      • Technical Analysis Rankings
        • RSI
        • GAPS
        • STIM
        • Daily Breakouts
        • Weekly Breakouts
        • Trends
        • Volatility
      • Top ranking ESG
        • ESG MSCI
        • Environment
        • Social
        • Governance
        • Islamic Finance
        • Paris Agreement
    Switch edition
    Stock BMY BRISTOL-MYERS SQUIBB COMPANY
    Add to a list

    Bristol-Myers Squibb Company

    Stocks

    BMY

    US1101221083

    Pharmaceuticals

    Market Closed - NYSE
    Other stock markets
    04:00:02 10/06/2026 HKT
    After hours 08:00:00
    56.48 USD +1.64% Intraday chart for Bristol-Myers Squibb Company 56.50 +0.04%
    06-10 Bristol-Myers Squibb Company Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 02:00 PM
    06-03 Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment MT
    Summary
    Quotes
    Charts
    Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
    News
    All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies
    Company
    Profile Governance Share ownership Insider transactions Group Connections
    Financials
    Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
    Valuation
    Valuation ratios Dividend
    Consensus
    Analysts' Opinion Estimates Revisions
    Ratings
    Calendar
    Sector
    Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
    ETFs
    All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

    Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says

    Published on 04/09/2026 at 11:06 pm HKT

    MT Newswires
    Share
    LockThis article is reserved for members
    Unlock the article: REGISTER NOW!
    100% Free Registration
    Already a customer? Log In
    mtnewswires logo
    © MT Newswires - 2026
    Share

    Latest news about Bristol-Myers Squibb Company

    06-10 Bristol-Myers Squibb Company Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 02:00 PM
    06-03 Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment MT
    06-03 Arcus to Supply Experimental Kidney Cancer Drug for Myers Squibb Trial DJ
    06-03 Arcus Biosciences, Inc. and Bristol Myers Squibb Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD-L1/VEGF-A Bispecific Immunomodulator to Treat Kidney Cancer CI
    06-03 HEALTH ROUNDS-Radiation-emitting implant improves outcomes after brain cancer surgery RE
    06-02 BSF Enterprise shares jump on paper in praise of "T-rex leather" AN
    06-01 Bristol Myers Squibb Wins EU Approval for Opdivo Combination in Advanced Classical Hodgkin Lymphoma MT
    06-01 Bristol Myers Gets Speedy FDA Review of Camzyos in Adolescents DJ
    06-01 Bristol Myers Squibb announces Opdivo® (nivolumab) in combination with Avd receives expanded EU label with approval in frontline advanced classical Hodgkin lymphoma RE
    06-01 U.S. FDA accepts for Priority Review Bristol-Myers Squibb's supplemental new drug application for Camzyos (mavacamten) RE
    06-01 Bristol Myers Squibb Announces A Supplemental New Drug Application CI
    06-01 Bristol Myers Squibb Announces Opdivo in Combination with Avd Receives Expanded Eu Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma CI
    05-30 Bristol-Myers Squibb Company Presents Positive Phase 3 Results For Mezigdomide In Combination With Carfilzomib And Dexamethasone In Relapsed Or Refractory Multiple Myeloma CI
    05-29 Jefferies Adjusts Price Target on Bristol-Myers Squibb to $73 From $70, Maintains Buy Rating MT
    05-29 Bristol-Myers Squibb Says Mezigdomide Combination Cuts Myeloma Progression Risk in Phase 3 Trial MT

    Chart Bristol-Myers Squibb Company

    Chart Bristol-Myers Squibb Company
    BMY: Dynamic Chart

    Company Profile

    Logo Bristol-Myers Squibb Company
    Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 69.1% of net sales.
    Employees
    32,500
    Sector
    Pharmaceuticals
    Calendar
    Earnings release - Q2 2026
    More about the company

    Income Statement and Estimates

    More financial data

    Analysis / Opinion

    Technical Analysis:  Bristol-Myers Squibb hesitates at a critical juncture

    Technical Analysis: Bristol-Myers Squibb hesitates at a critical juncture

    August 28, 2025 at 03:51 pm

    More analyses

    Ratings

    Trader

    Trader

    This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

    Investor

    Investor

    This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

    Global

    Global

    This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.

    Quality

    Quality

    This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

    ESG MSCI

    ESG MSCI

    The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

    A
    More Ratings

    Analysts' Consensus

    Sell
    Consensus
    Buy
    Mean consensus
    OUTPERFORM
    Number of Analysts
    29
    Last Close Price
    56.48USD
    Average target price
    63.08USD
    Spread / Average Target
    +11.69%
    Consensus
    EPS Estimates
    Revisions to estimates

    Quarterly revenue - Rate of surprise

    Company calendar
    Indices Europe America Asia
    My Watchlist
     

    My lists
    Rankings
     

    More Rankings
    Rankings
     

    More Rankings

    Currency / Forex

    Commodities

    Cryptocurrencies

    Interest Rates

    1. Stock Market
    2. Stock Market News
    3. Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says
    Best financial portal

    Best financial
    portal

    More than 20 yearsat your side

    More than 20 years
    at your side

    Trustpilot
    + 1,300,000members

    + 1,300,000
    members

    Quick & easycancellation

    Quick & easy
    cancellation

    Our Expertsare here for you

    Our Experts
    are here for you

    Download from Apple Store

    OUR EXPERTS ARE HERE FOR YOU

    Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

    Contact us
    MarketScreener, Stock Market Live
    Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
    Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
    40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
    d
    :
    :
    BENEFIT NOW

    Select your edition

    All financial news and data tailored to specific country editions

    NORTH AMERICA

    MarketScreener
    United-States
    MarketScreener Canada
    Canada

    MIDDLE EAST

    MarketScreener Saudi Arabia
    Saudi Arabia
    MarketScreener UAE Emirates
    United Arab Emirates

    EUROPE

    Zonebourse
    France
    MarketScreener Deutschland
    Deutschland
    Zonebourse Suisse
    Suisse
    MarketScreener Schweiz
    Schweiz
    MarketScreener Italia
    Italia
    MarketScreener Österreich
    Österreich
    MarketScreener België
    België
    MarketScreener Nederland
    Nederland
    MarketScreener España
    España
    MarketScreener Sverige
    Sverige
    MarketScreener UK
    United Kingdom

    APAC

    MarketScreener Australia
    Australia
    MarketScreener India
    India
    MarketScreener Hong Kong
    Hong Kong